PURPOSE. Some 30% of cases of congenital cataract are genetic in origin, usually transmitted as an autosomal dominant trait. The molecular defects underlying some of these autosomal dominant cases have been identified and were demonstrated to be mostly mutations in crystallin genes. The autosomal recessive form of the disease is less frequent. To date, only four genes and three loci have been associated with autosomal recessive congenital cataract. Two extended unrelated consanguineous inbred Bedouin families from southern Israel presenting with autosomal recessive congenital nuclear cataract were studied. METHODS. Assuming a founder effect, homozygosity testing was performed using polymorphic microsatellite markers adjacent to each of 32 candidate genes. RESULTS. A locus on chromosome 22 surrounding marker D22S1167 demonstrated homozygosity only in affected individuals (lod score Ͼ 6.57 at ϭ 0 for D22S1167). Two crystallin genes (CRYBB1 and CRYBA4) located within 0.1 cM on each side of this marker were sequenced. No mutations were found in CRYBA4. However, an identical homozygous delG168 mutation in exon 2 of CRYBB1 was discovered in affected individuals of both families, generating a frameshift leading to a missense protein sequence at amino acid 57 and truncation at amino acid 107 of the 252-amino-acid CRYBB1 protein. 
I
n the developed world, the incidence of congenital cataract is 30 per 100,000 live births. 1 At least a third of such cases are familial. 2 Congenital cataracts may occur as an isolated anomaly, as part of generalized ocular developmental defects (nonsyndromic) or as a component of a multisystem syndrome. Although some congenital cataract loci have been determined in humans by genetic linkage analysis, [2] [3] [4] [5] many genes that are involved have yet to be determined.
The transparency of the normal eye lens is dependent on its ability to express a high concentration of crystallin proteins. A higher concentration of such proteins corresponds to a higher refractivity of the medium. Crystallins are highly stable major constituents of the vertebrate eye lens and comprise approximately 90% of the water-soluble lens proteins. 6 -8 They have a particular spatial arrangement critical to the transparency of the lens 9 and are hence good candidate genes for congenital cataract disease. 6 The three major classes of crystallins in the human lens-␣-, ␤-, and ␥-crystallin-are distinguishable by size, charge, and immunologic properties. The amino-and carboxyl terminal extensions of ␤-crystallins are presumed to be of importance in protein aggregation and orientation. 10 Crystallin genes, which encode major structural proteins in the lens, are considered as obvious candidate genes of congenital cataracts owing to both their high levels of lenticular expression and their confirmed functions in maintaining lens transparency. Increasing evidence suggests the correlated relationship between mutations in the crystallin genes with the occurrence of congenital cataracts in humans.
11 Several reports indicate that mutations in mammalian crystallin genes are associated with congenital cataracts, 12 providing concurring evidence.
Autosomal dominant, highly penetrant mutations of ␤-crystallins appear to be the most common cause of congenital cataract disorders, [13] [14] [15] [16] [17] [18] and, when present, typically occur in both eyes. 4 However, different mutations in the human CRYAA crystallin gene have been deduced to have different patterns of inheritance: a case of recessive inheritance in ␣A-crystallin (CRYAA) has been reported in a Persian Jewish family. 2 Other cases of autosomal recessive congenital cataract have been associated with homozygous mutations in CRYBB3, 19 as well as in several noncrystallin genes. 20, 21 In the present study, two large inbred Bedouin families from southern Israel were found to have an autosomal recessive form of congenital cataract. Assuming a homozygous mutation due to a founder effect, the locus wherein lies the expected mutation was sought.
MATERIALS AND METHODS

Patients
Two unrelated Israeli Bedouin families were recruited and comprised 14 patients with congenital cataracts and 21 unaffected individuals. The patients were offspring of consanguineous marriages, suggesting that the disorder was due to a founder mutation in each family. The pedigrees are depicted in Figure 1 . This study was approved by the Israeli National Genetics Helsinki Committee and the Soroka Medical Centre Institutional Review Board. Written informed consent was obtained from all subjects in accordance with the Declaration of Helsinki. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Ohad S. Birk, The Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; obirk@bgu.ac.il.
Clinical Details
The phenotype was determined via ophthalmic examination, which included the best corrected visual acuity (Snellen's), slit lamp biomicroscopy, and fundus examination. All affected individuals had bilateral confluent nuclear opacification. 22 All except two children underwent bilateral nonsimultaneous lens washout and posterior chamber intraocular lens implantation. Age at the procedure ranged between 19 and 51 months (average 31 months; median 29 months). In two children, the nuclear opacities were mild and surgery was deferred.
Linkage and Haplotype Analysis
Genomic DNA was extracted from whole blood (FlexiGene DNA AGF3000 Kit; Qiagen, Valencia, CA) per the kit instructions. Polymorphic microsatellites flanking 32 candidate genes ( of Technology, Cambridge, MA) used to design primers for PCR amplification. PCR amplification of flanking markers for each of these genes (primer sequences available on request) was performed according to standard procedures. All PCR reactions were as follows: denaturation at 95°for 1 minute, followed by 35 cycles of 95°for 30 seconds, 55°for 30 seconds, and 72°for 30 seconds, and a final extension at 72°for 7 minutes. Products were separated by electrophoresis on a 6% polyacrylamide gel and visualized thereafter by silver staining. 23 Haplotypes were constructed manually and analyzed. Primers used for PCR amplification of polymorphic markers adjacent to the CRYBB1 gene were: D22S1167 (forward: 5ЈACATGGCAAAACCCAGTCTC3Ј, reverse: 5Ј-GGGGCTTCAACAACATTCTTAAC-3Ј); D22S419 (forward: 5Ј-GGCT-CAGGGACTCTGGA-3Ј, reverse: 5Ј-GGCCAATCGGTAGGTCA-3Ј); and D22S1144 (forward: 5Ј-GCTGAAATTGCCAAAGTTTA-3Ј, reverse: 5Ј-GAGCCTCTGGTCCTCTGT-3Ј). All PCR reactions were performed using PCR master mix (ABgene, Epsom, UK). Linkage was demonstrated by using Superlink, 24 assuming autosomal recessive heredity of the phenotype.
PCR Amplification of Genomic DNA for Sequencing
Primers designed to amplify exon 2 of the CRYBB1 gene (GenBank accession number: gi: 21536279; http://www.ncbi.nlm.nih.gov/Genbank; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD): forward: 5Ј-acaggatgtggggctatgag-3Ј and reverse: 5Ј-gtgcggaggagtaagaggtg-3Ј. The reaction was performed with PCR master mix (ABgene), and conditions were as follows: denaturation at 95°for 1 minute, followed by 35 cycles at 95°f or 30 seconds, 58°for 30 seconds, and 72°for 30 seconds, and a final extension at 72°for 7 minutes.
DNA Sequencing
PCR products were gel purified (Qiagen), according to the manufacturer's instructions, and sequenced in both forward and reverse directions with the primers used in the respective PCR amplifications. Sequencing was performed with dye-termination chemistry (Prism BigDye terminator cycle sequencing kit; Applied Biosystems, Inc.
[ABI], Foster City, CA, and PRISM 377 DNA sequencer; ABI). A second DNA sample from each patient was tested to confirm mutations identified during the first round of sequencing, with two different PCR products being sequenced for each.
Mutation Analysis
The CRYBB1 gene which showed linkage to congenital cataracts was sequenced using primers designed by using the National Center for Biotechnology Information (NCBI) database and Primer3 software. PCR products were separated by electrophoresis on agarose gels and kit purified (Qiagen). Products were bidirectionally sequenced (Prism 377 DNA Sequencer; ABI) and analyzed by using Chromas software (Technelysium Pty Ltd., Tewantin QLD, Australia).
Comparison to published DNA sequences was thereafter performed. Further analysis of the deletion in exon 2 of the CRYBB1 gene was performed with denaturing high-performance liquid chromatography (dHPLC), on PCR-amplified genomic DNA samples (WAVE system; Transgenomic, Elancourt, France), according to the manufacturer's protocol. Elution of PCR products from the column was effected by using an acetonitrile gradient in 0.1 M triethylamine acetate buffer (pH 7), at a constant flow rate of 0.9 mL ⅐ min Ϫ1 . The melting profile of the PCR product determined the temperature at which heteroduplex detection occurred and was calculated with the system software (WaveMaker software; Transgenomic). The DNA fragments were analyzed with a total run time of 7.8 minutes per sample. The linear acetonitrile gradient was adjusted to ensure that the relevant fragments were eluted between 4.5 and 5.5 minutes.
FIGURE 2.
Linkage analysis at the CRYBB1 locus. Individuals 1 to 7 belong to family 2, and individuals 8 to 11 belong to family 1 (Fig. 1 ). All patients (3, 4, 6, and 11 are shown) in both families exhibited a homozygous genotype for the polymorphic marker D22S1167. Their parents (individuals 1, 2, 8, and 9) were heterozygous carriers. 
RESULTS
Two large Israeli Bedouin extended families from the Negev desert, presenting with autosomal recessive congenital bilateral nuclear cataracts, were studied. Figure 1 depicts the two pedigrees. At the time of study, 14 patients existed, and linkage to 32 candidate genes was sought (Table 1) . Twenty-one unaffected family members were also tested to generate haplotypes with two polymorphic markers flanking each gene. Linkage was ruled out for all loci tested, except for the CRYBB1 locus (results not shown). Studies using polymorphic markers at the CRYBB1 locus, shown in Figures 1 and 2 , demonstrated that all patients in family 1 (Fig. 1A) were homozygous for a haplotype of three microsatellite markers flanking CRYBB1 and that all their nonaffected parents were heterozygous carriers of that haplotype. In family 2 (Fig. 1B) , there were several crossover events at that locus in the various branches of this larger kindred, with several individuals marrying more distant relatives. Yet, in affected individuals of kindred 2, there was consistent homozygosity for the same allele of D22S1167 (that is immediately adjacent to CRYBB1), as in affected individuals of kindred 1 (Fig. 1A) . A significant lod score of 6.57 at ϭ 0 was obtained for D22S1167, a polymorphic marker residing within 0.1 cM of two ␤-crystallin genes, CRYBB1 and CRYBA4, known to encode proteins expressed in lens tissue. No mutations were found in CRYBA4. However, as shown in Figure 3A , an identical homozygous delG168 mutation in exon 2 of CRYBB1 was demonstrated in affected individuals of both families, generating a frameshift (and missense protein sequence) as of amino acid 57 and a stop codon causing truncation after amino acid 107. dHPLC studies (Fig. 3B) showed that all affected individuals of both families were homozygous for the mutation, all parents of affected individuals were heterozygous for the mutation, whereas none of 100 unrelated Bedouin individuals from southern Israel carried the mutation.
DISCUSSION
Congenital cataracts frequently cause blindness in children. In this work, an autosomal recessive form of congenital cataracts 21 and 19q13. 27 It should be noted that ␤B2-crystallin dominant mutations were shown to be associated with congenital cataracts, yet for at least for one of these mutations, the phenotype in a homozygous mutant individual was significantly more severe than in heterozygotes. 28 In humans, ␣-crystallin is encoded by two closely related genes: the ␣A-and ␣B-crystallin genes. The ␤-crystallin family consists of four acidic (A) and three basic (B) protein forms. 29 Defects in crystallin genes have previously been shown to be associated with human cataract formation, mostly as a dominant trait. 8 Mackay et al. 16 demonstrated that congenital cataract can result from a dominant mutation in exon 6 of the ␤-crystallin gene, CRYBB1. It is of interest that both the Q155X mutation in CRYBB2 12 and the G220X mutation in CRYBB1 16 disrupt the fourth Greek key motif, probably causing instability of the molecule. 16 Willoughby et al. 30 published evidence of another dominant mutation in CRYBB1 associated with the phenotype in conjunction with microcornea. This mutation, also in exon 6 of the gene, generated an X253R change in the protein sequence, leading to elongation of the C-terminal extension of the protein. Although it was suggested that this elongation interferes with ␤-crystallin interactions, this was not proven experimentally. 30 Heredity in all these cases was dominant.
In the present study, we demonstrate a recessively inherited congenital cataract condition caused by a frameshift mutation in CRYBB1 that fully abrogates the C-terminal extension. ␤B1-crystallin comprises approximately 9% of all soluble crystallins in the human lens. 31 Loss of the terminal arms can either increase or decrease dimerization of the ␤-crystallins. 32 It seems likely that the C-terminal extensions affect higher order aggregation, although the evidence of this is indirect, being the preferential occurrence of ␤B1-crystallin in ␤-high peak on size-exclusion chromatography. 33 The mutation characterized is distinct from those reported by Mackay et al. 16 and Willoughby et al. 30 It occurs within the same gene, but results in a recessive trait rather than a dominant one. The two previously described CRYBB1 mutations, 16, 30 both in exon 6 of the gene, were such that caused alterations in the extension region (Greek key motif) of the protein, probably leading to instability of the molecule. 16 In contrast with the previously described CRYBB1 mutations, the mutation we demonstrate is in exon 2 of the gene and abrogates the protein very near to its N terminus (at amino acid 57 of the original 252-amino-acid protein). Thus, the extension region of the molecule (encoded by exon 6 of the gene) is nonexistent in the mutant protein and it is thus likely that the mutant protein cannot exert any dominant effects through dimerization with wild-type molecules. There is a strong possibility that the frameshift and premature truncation lead to nonsense-mediated decay 34 and thus no protein product, which would be consistent with a recessive phenotype.
